US2023310517A1PendingUtilityA1

Compositions comprising bacterial strains

77
Assignee: 4D PHARMA RES LIMITEDPriority: Jun 15, 2015Filed: Jan 5, 2023Published: Oct 5, 2023
Est. expiryJun 15, 2035(~8.9 yrs left)· nominal 20-yr term from priority
Inventors:George GrantAngela Margaret PattersonImke Elisabeth MulderSeanin MccluskeyEmma Raftis
A61K 35/74C12N 1/205A23L 33/30A23L 33/135A61K 9/19C12R 2001/01A61P 11/06A61P 19/02A61P 29/00A61P 17/06A61P 37/08A61P 35/00A61P 27/02A61P 9/10A61P 11/00A61P 11/02A61P 1/02A61P 1/04A61P 1/00A61P 37/06A61P 17/00A61P 17/04A61P 19/00A61P 19/08A61P 25/00A61P 25/02A61P 25/28A61P 27/00A61P 35/04A61P 37/00A61P 37/02A61P 43/00A61P 9/00A61K 35/747Y02A50/30A61K 2035/11A23V 2200/314A23V 2002/00
77
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention provides compositions comprising bacterial strains for treating and preventing inflammatory and autoimmune diseases.

Claims

exact text as granted — not AI-modified
1 . A composition comprising a bacterial strain of the genus  Parabacteroides , for use in a method of treating or preventing a disease or condition mediated by IL-17 or the Th17 pathway. 
     
     
         2 .- 35 . (canceled)

Join the waitlist — get patent alerts

Track US2023310517A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.